Workflow
皖仪科技(688600) - 2020 Q2 - 季度财报
WANYI SCIENCEWANYI SCIENCE(SH:688600)2020-08-27 16:00

Financial Performance - The company's operating revenue for the first half of 2020 was ¥137,348,308.27, a decrease of 6.83% compared to ¥147,411,820.62 in the same period last year[18]. - The net profit attributable to shareholders of the listed company was ¥1,730,190.07, down 62.05% from ¥4,559,429.85 in the previous year[18]. - The net profit after deducting non-recurring gains and losses was -¥8,374,834.10, a decline of 210.41% compared to ¥7,585,060.20 in the same period last year[18]. - The net cash flow from operating activities was -¥614,641.28, showing an improvement from -¥21,354,446.74 in the previous year[18]. - Basic and diluted earnings per share decreased by 60% to 0.02 yuan per share compared to the same period last year[19]. - The total profit for the first half of 2020 was RMB 3,179,463.95, a decrease of 34.7% from RMB 4,865,843.56 in the same period last year[132]. Assets and Liabilities - The net assets attributable to shareholders of the listed company increased by 145.24% to ¥776,770,930.64 from ¥316,738,338.43 at the end of the previous year[18]. - Total assets rose by 89.74% to ¥950,658,015.83 from ¥501,030,242.16 at the end of the previous year[18]. - The company reported accounts receivable amounted to CNY 109.22 million, representing 12.73% of current assets, with 34.07% of accounts receivable aged over one year, indicating potential liquidity risks[56]. - Total current assets reached ¥858,129,516.56, up from ¥401,611,425.68 at the end of 2019[123]. - The total liability of CNY 169,251,873.66, down from CNY 180,261,046.42, a decrease of 6.0%[125]. Research and Development - The company's R&D investment accounted for 20.60% of operating revenue, an increase of 3.68 percentage points year-on-year, reflecting a continued commitment to innovation[19]. - The company achieved a total R&D investment of ¥28,297,404.87, which represents 20.60% of its operating revenue[34]. - The company has a total of 229 R&D personnel, accounting for 27.46% of the total workforce[43]. - The company is currently working on a small COD online monitoring instrument with a total investment of ¥6,000,000, which has achieved a measurement accuracy of ±10% or ±3mg/L[37]. - The company is developing an intelligent ultra-high-performance liquid chromatography project with a total investment of ¥120,000,000, which has shown significant improvements in detection speed and environmental impact[37]. Market Position and Strategy - The company operates in the environmental monitoring instrument sector, focusing on high-end analysis and detection instruments, with a strong emphasis on R&D and market expansion[26][29]. - The company maintains a competitive position in the domestic market for leak detection instruments, achieving import substitution and establishing a strong brand image[29]. - The company is focused on expanding its market presence in environmental monitoring technologies, aiming to enhance product offerings and customer satisfaction[39]. - The company is expanding its market presence, particularly in the lithium battery leak detection sector and the semiconductor industry, while also increasing its sales network in major industrial provinces in China[53]. Government Support and Subsidies - Government subsidies received during the reporting period totaled CNY 15.54 million, accounting for 488.73% of the total profit, highlighting the company's reliance on government support[57]. Compliance and Governance - The company has established a comprehensive quality control system based on GB/T19001-2016/ISO9001:2015 standards[47]. - The management emphasized the importance of compliance with regulatory requirements in all operational strategies moving forward[80]. - The company reported a commitment to fulfill all obligations and responsibilities made during the initial public offering process[99]. Future Outlook - The company plans to continue focusing on R&D and market expansion strategies to improve future performance[135]. - The company expects a potential net profit loss or significant fluctuation compared to the same period last year due to increased R&D investments and the impact of the pandemic on product acceptance and market promotion[70]. - The company will continue to increase R&D investment in the second half of the year to provide high-performance products, with benefits expected to improve gradually over time[70].